You are here
Bristol-Myers vulnerable to takeover after setback in cancer drug
AT a Chicago convention jammed with thousands of doctors in 2015, a buzz of excitement rippled through the hall as a researcher revealed data showing that a Bristol-Myers Squibb Co drug cocktail had remarkable success in fighting a deadly form of skin cancer.
It was a
- CALL +65 6388 3838
- EMAIL email@example.com